| abstract |
Provided is a method of administering pirfenidone to patients with abnormal liver function biomarker levels by pirfenidone dosing. According to the method, the patient is given a dose of pirfenidone less than the total amount of treatment for a predetermined period of time, and then the patient is dosed with the full amount of pirfenidone. The method also includes a method of administering the total amount of treatment without lowering the amount of pirfenidone and a method of lowering the amount of pirfenidone throughout the treatment period. |